your market intelligence analyst
Search Results
10 results
Your search is now limited to «Celgene» expert search.
Human medicines European public assessment report (EPAR): Thalidomide Celgene (previously Thalidomide Pharmion), thalidomide, Multiple Myeloma, Date of authorisation: 16/04/2008, Revision: 24, Status: Authorised.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios